When drug company chief executive Heather Bresch was hauled in front of Congress last year to defend the high price of lifesaving EpiPens, she drew skeptical lawmakers’ attention to a large poster board that blamed the skyrocketing price tag on a coterie of drug supply chain middlemen. Of EpiPen’s $608 list price, her company, Mylan, received only $274, Bresch said.
Ten years ago, the average gram of meth available in the U.S. was 39-percent pure. Today, it is being sold in a nearly pure state, manufactured in Mexican "superlabs" and smuggled across the border to feed an epidemic of addiction.
Drugmakers in the EU are warning of drug supply chaos if the U.K. and European Commission can't strike a specific deal covering the approval of medicines before their governmental divorce.
Three years ago, GlaxoSmithKline set up an online Supplier Exchange to enlist suppliers in a bid to meet carbon-reduction goals. Now it's found a familiar partner to manage that community.
About a hundred years ago, common jobs included manufacturing positions, roles in agriculture and artisan services. Today, occupations in health care, computers and construction are on the rise. Technology and society's changing needs mean the workforce is constantly evolving.
The latest supply-chain news, analysis, trends and tools for executives in the healthcare industry. Learn how healthcare companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.